The controversial psychiatrist who said Michelle Carter was on antidepressants and involuntarily intoxicated when she sent text messages encouraging her high school boyfriend to kill himself will be able to testify during her upcoming trial, a judge has ruled.
“The Court is satisfied as to the qualifications of Dr. (Peter) Breggin to testify as an expert, based upon his education, training, experience and familiarity with the subject matter of his proposed testimony,” Superior Court Judge Lawrence Moniz wrote yesterday.
Breggin in a March hearing testified that Carter, now 20, was being treated with the antidepressant Celexa, and the drug altered her developing teen brain when she told her boyfriend, Conrad Roy III, to kill himself via a series of texts on July 13, 2014.
“The stuff in the texting was out of her range,” Breggin, 80, said during the hearing to determine whether he will be allowed to testify at trial. “It was beyond anything I have ever seen before in terms of character changes, personality changes, behavior changes, attitude changes … for that brief period of time.”
Bristol prosecutors fought to have Breggin barred from testifying, pointing to a publication that labeled him a “self-described extremist.”
But Moniz found that Breggin “has been many times qualified in such areas to testify as an expert,” and that in this case, he should be able to take the stand.
Roy was also taking Celexa at the time of his suicide, and Breggin will be able to testify as to the effect the drug may have had on him.
“The possible impact said medications might have on each and both of these individuals is relevant to the determinations to be made by the trier of fact, as to both individuals,” Moniz wrote.
By Bob McGovern